Seventh TRM Forum on Computer Simulation and Experimental Assessment of Cardiac Function: creating the basis for tailored therapies.

Europace

Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland Center of Computational Medicine in Cardiology, Università della Svizzera Italiana, Lugano, Switzerland.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euu253DOI Listing

Publication Analysis

Top Keywords

seventh trm
4
trm forum
4
forum computer
4
computer simulation
4
simulation experimental
4
experimental assessment
4
assessment cardiac
4
cardiac function
4
function creating
4
creating basis
4

Similar Publications

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric acute megakaryoblastic leukemia without Down syndrome in China: A single-center study.

Front Oncol

February 2023

Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Background: AMKL without DS is a rare but aggressive hematological malignant disease in children, and it is associated with inferior outcomes. Several researchers have regarded pediatric AMKL without DS as high-risk or at least intermediate-risk AML and proposed that upfront allogenic hematopoietic stem cell transplantation (HSCT) in first complete remission might improve long-term survival.

Patients And Method: We conducted a retrospective study with twenty-five pediatric (< 14 years old) AMKL patients without DS who underwent haploidentical HSCT in the Peking University Institute of Hematology, Peking University People's Hospital from July 2016 to July 2021.

View Article and Find Full Text PDF

Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis".

J Hepatol

December 2022

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, Missenden Road, Camperdown, NSW 2050, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney, Sydney, NSW 2006, Australia. Electronic address:

View Article and Find Full Text PDF

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.

J Hepatol

February 2022

Drug Health Services, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia; Faculty of Medicine and Health, the University of Sydney, Sydney, NSW 2006, Australia; Centenary Institute of Cancer Medicine and Cell Biology, the University of Sydney, Sydney, NSW 2006, Australia. Electronic address:

Background & Aims: Only a minority of excess alcohol drinkers develop cirrhosis. We developed and evaluated risk stratification scores to identify those at highest risk.

Methods: Three cohorts (GenomALC-1: n = 1,690, GenomALC-2: n = 3,037, UK Biobank: relevant n = 6,898) with a history of heavy alcohol consumption (≥80 g/day (men), ≥50 g/day (women), for ≥10 years) were included.

View Article and Find Full Text PDF

A comparative microbiological study of polyglycolic acid and silk sutures in oral surgical procedures.

Minerva Dent Oral Sci

December 2021

Department of Oral and Maxillofacial Surgery, Sri Siddhartha Dental College and Hospital, Sri Siddhartha University, Tumkur, India.

Background: Bacterial adherence to silk and polyglycolic acid suture is similar. Literature has shown bacterial adhesion is lower degree in polyglycolic acid suture compared to silk, but tissue reaction was more in the polyglycolic acid suture. The aim of the study was to compare the bacteria adhered on the silk and polyglycolic acid sutures.

View Article and Find Full Text PDF

Background: MB66 film is a multipurpose prevention technology (MPT) product with monoclonal antibodies (mAbs) against HIV-1 (VRC01-N) and HSV-1 and 2 (HSV8-N). The mAbs were produced by transient expression in Nicotiana benthamiana (N). We conducted a Phase I clinical trial to assess the safety, pharmacokinetics (PK), and ex vivo efficacy of single and repeated doses of MB66 when used intravaginally.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!